Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
clinical trials
europe blog main
europe top stories
national
abbvie
alzheimer's disease
amgen
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chronic kidney disease
deals
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
merck
moderna
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
startups
What
week
4
×
bio
ceo
companies
debut
drug
life
moves
roundup
science
street
wall
aces
acquisitions
announced
arrival
big
biggest
biotech
black
build
buy
cholesterol
company’s
continue
daniel
days
diamond
diamond’s
dyne’s
flexible
gilead
hasn’t
inclisiran
indication
industry
ipo
ipos
key
leading
Language
unset
4
×
Current search:
week
×
" boston top stories "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing